NAD, Institutional Access - Northeast / North Atlantic
CorMedix Therapeutics
August 11, 2026
Remote friendly (Baltimore, MD)
United States
$191,000 - $255,000 USD yearly
Market Access
Primary Responsibilities
- Serve as primary corporate account lead for targeted organized customers and decision-makers for priority IDNs.
- Develop and execute national account strategies across IDNs, academic medical centers, large health systems, and cancer centers.
- Engage with pharmacy leadership, supply chain, finance, population health, quality, and clinical stakeholders to support access objectives.
- Lead engagement plans to improve formulary access, operational readiness, reimbursement optimization, and financial adoption.
- Support health system and organized customer contracting strategies; collaborate with Pricing, Trade, and Contracting.
- Provide strategic input on payer/provider dynamics affecting adoption and utilization; identify adoption barriers and develop customized solutions.
- Coordinate customer engagement with Market Access, Sales, Medical Affairs, Trade, HEOR, Compliance, Legal, Finance, and Patient Services.
Pre-Approval Information Exchange (PIE)
- Lead compliant PIE engagements for upcoming launches or label expansions.
- Deliver FDA-compliant clinical/economic/operational value messaging; educate on product impact, reimbursement pathways, coding, and implementation.
- Develop/present budget impact analyses, pro forma models, and economic value assessments.
- Quantify financial implications (acquisition cost, reimbursement, site-of-care economics, infection/readmission reduction, operational efficiencies, patient outcomes).
Revenue Cycle & Reimbursement Expertise
- Advise on revenue cycle operations: coding/billing, DRG/APC, NTAP/pass-through, buy-and-bill, specialty pharmacy/medical benefit reimbursement, charge capture/claims adjudication.
- Identify reimbursement risks and develop mitigation strategies.
HUB & Patient Services Collaboration
- Partner with HUB/patient support to optimize onboarding, benefit verification, prior authorization, financial assistance, and therapy access.
- Ensure stakeholders understand support services/workflows; provide feedback to improve HUB program effectiveness.
Account Planning & Execution
- Build national account plans (stakeholder mapping, opportunity identification, financial analyses, access strategies).
- Drive execution, performance metrics, pull-through initiatives; monitor market/policy/reimbursement trends.
- Maintain account documentation, forecasting, and reporting.
Skills & Requirements
- Strong payer/provider economics knowledge (inpatient/outpatient).
- Proven ability to engage/influence executive-level stakeholders.
- Strong analytical, financial modeling, and presentation skills.
- Excellent cross-functional leadership/collaboration.
Qualifications
- Bachelor’s degree required; MBA/MPH/PharmD/MS or related preferred.
- 8–12+ years experience in pharma/biotech/specialty pharmacy/healthcare consulting/market access.
- Significant experience with IDNs, academic medical centers, organized health systems, and institutional customers.
- Travel up to 50%; national travel as required.
- Serve as primary corporate account lead for targeted organized customers and decision-makers for priority IDNs.
- Develop and execute national account strategies across IDNs, academic medical centers, large health systems, and cancer centers.
- Engage with pharmacy leadership, supply chain, finance, population health, quality, and clinical stakeholders to support access objectives.
- Lead engagement plans to improve formulary access, operational readiness, reimbursement optimization, and financial adoption.
- Support health system and organized customer contracting strategies; collaborate with Pricing, Trade, and Contracting.
- Provide strategic input on payer/provider dynamics affecting adoption and utilization; identify adoption barriers and develop customized solutions.
- Coordinate customer engagement with Market Access, Sales, Medical Affairs, Trade, HEOR, Compliance, Legal, Finance, and Patient Services.
Pre-Approval Information Exchange (PIE)
- Lead compliant PIE engagements for upcoming launches or label expansions.
- Deliver FDA-compliant clinical/economic/operational value messaging; educate on product impact, reimbursement pathways, coding, and implementation.
- Develop/present budget impact analyses, pro forma models, and economic value assessments.
- Quantify financial implications (acquisition cost, reimbursement, site-of-care economics, infection/readmission reduction, operational efficiencies, patient outcomes).
Revenue Cycle & Reimbursement Expertise
- Advise on revenue cycle operations: coding/billing, DRG/APC, NTAP/pass-through, buy-and-bill, specialty pharmacy/medical benefit reimbursement, charge capture/claims adjudication.
- Identify reimbursement risks and develop mitigation strategies.
HUB & Patient Services Collaboration
- Partner with HUB/patient support to optimize onboarding, benefit verification, prior authorization, financial assistance, and therapy access.
- Ensure stakeholders understand support services/workflows; provide feedback to improve HUB program effectiveness.
Account Planning & Execution
- Build national account plans (stakeholder mapping, opportunity identification, financial analyses, access strategies).
- Drive execution, performance metrics, pull-through initiatives; monitor market/policy/reimbursement trends.
- Maintain account documentation, forecasting, and reporting.
Skills & Requirements
- Strong payer/provider economics knowledge (inpatient/outpatient).
- Proven ability to engage/influence executive-level stakeholders.
- Strong analytical, financial modeling, and presentation skills.
- Excellent cross-functional leadership/collaboration.
Qualifications
- Bachelor’s degree required; MBA/MPH/PharmD/MS or related preferred.
- 8–12+ years experience in pharma/biotech/specialty pharmacy/healthcare consulting/market access.
- Significant experience with IDNs, academic medical centers, organized health systems, and institutional customers.
- Travel up to 50%; national travel as required.